A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

AIMS: There is no cure for pulmonary arterial hypertension, but current approved treatment options include prostanoids, endothelin-receptor antagonists, and phosphodiesterase type-5 inhibitors. The effect on survival of these compounds has not been appropriately assessed in individual trials because...

Descripción completa

Detalles Bibliográficos
Autores principales: Galiè, Nazzareno, Manes, Alessandra, Negro, Luca, Palazzini, Massimiliano, Bacchi-Reggiani, Maria Letizia, Branzi, Angelo
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
FASTTrack
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642921/
https://www.ncbi.nlm.nih.gov/pubmed/19155250
http://dx.doi.org/10.1093/eurheartj/ehp022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642921/
https://www.ncbi.nlm.nih.gov/pubmed/19155250
http://dx.doi.org/10.1093/eurheartj/ehp022

Ejemplares similares